Document Type : Original Article(s)
Authors
1 Department of Public Health, Torbat-Jam Faculty of Medical Sciences, Torbat-Jam, Iran
2 HIV/AIDS Control Office, Center for Communicable Diseases, Ministry of Health, Tehran, Iran
3 Student Research Committee, Faculty of Health, Isfahan University of Medical Sciences, Isfahan, Iran
4 Department of Epidemiology and Biostatistics, Faculty of Health, Isfahan University of Medical Science, Isfahan, Iran
5 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: In 2022, human immunodeficiency virus (HIV) affected 39 million globally, with Iran experiencing a concentrated epidemic. This study aimed to identify and prioritize critical HIV/AIDS research areas to address existing gaps in the Iranian context.
Methods: Researchers at Isfahan University of Medical Sciences employed a three-phase approach between May 2018 and March 2023. The first phase involved developing an HIV research matrix tailored to international guidelines and the Iranian context. In the second phase, a systematic review of HIV-related studies in Iran was conducted following the PRISMA protocol to assess quality and relevance. The third phase utilized a three-round Delphi method to collect expert feedback, which was used to prioritize research areas based on their importance and feasibility.
Results: A systematic review of 6,310 sources yielded 745 documents for full-text analysis. Key research domains identified included prevention, diagnosis, care and treatment, epidemiology, and co-infections. Quantitative analysis indicated that 23% of studies focused on co-infections, while ethical issues were addressed in only 0.04%. Qualitative assessment revealed that 54% of reviewed studies were of low quality. Subsequent expert consultation and multi-criteria decision analysis ranked laboratory research and co-infections as the highest priorities. Specific sub-areas identified included molecular epidemiology and interventions addressing stigma and discrimination. Despite being highly cost-effective and urgently needed, research on stigma-related interventions exhibited a significant gap.
Conclusion: The study identified 11 main research areas and 60 sub-areas as priorities for HIV/AIDS research in Iran, highlighting the need for strategic funding and research planning. Ethical considerations and laboratory improvements are essential for enhancing public health outcomes and addressing emerging challenges in the HIV epidemic.
Highlights
Forugh Aleebrahim (Google Scholar)
Maryam Nasirian (Google Scholar)
Keywords
- Aliyu MH, Varkey P, Salihu HM, Iliyasu Z, Abubakar IS. The HIV/AIDS epidemic in Nigeria: progress, problems and prospects. Afr J Med Med Sci. 2010;39:233-9. PubMed PMID: 21416794.
- Raeisi A, Tabrizi JS, Gouya MM. IR of Iran National Mobilization against COVID-19 Epidemic. Arch Iran Med. 2020;23:216-9. doi: 10.34172/aim.2020.01. PubMed PMID: 32271593.
- Kimera E, Vindevogel S, Reynaert D, Justice KM, Rubaihayo J, De Maeyer J, et al. Experiences and effects of HIV-related stigma among youth living with HIV/AIDS in Western Uganda: A photovoice study. PLoS One. 2020;15:e0232359. doi: 10.1371/journal.pone.0232359. PubMed PMID: 32330206; PubMed Central PMCID: PMCPMC7182188.
- Center for Infectious Disease Management [Internet]. Report of recorded cases of HIV infection in the Islamic Republic of Iran until the end of September 2023. [02 Desemder 2023]. Available from: https://icdc.behdasht.gov.ir/AIDS_status. Persian.
- SeyedAlinaghi S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, Abedinzadeh N, McFarland W, et al. HIV in Iran: onset, responses, and future directions. AIDS. 2021;35:529-42. doi: 10.1097/QAD.0000000000002757. PubMed PMID: 33252485; PubMed Central PMCID: PMCPMC7924262.
- Haghdoost AA, Mirzazadeh A, Nedjat S, Navadeh S, Mansournia MA, McFarland W. Bio-behavioral surveillance of women sex workers project report: Center for communicable disease management, Iran. Regional Knowledge Hub for HIV/AIDS Surveillance at Kerman University of Medical Sciences; 2010.
- Al-Ghafri Q, Radcliffe P, Gilchrist G. Barriers and facilitators to accessing inpatient and community substance use treatment and harm reduction services for people who use drugs in the Muslim communities: A systematic narrative review of studies on the experiences of people who receive services and service providers. Drug Alcohol Depend. 2023;244:109790. doi: 10.1016/j.drugalcdep.2023.109790. PubMed PMID: 36805826.
- Mohseni TA, Hekmatpour P. HIV/AIDS related stigma in Iran: A qualitative study. International Journal of Social Sciences. 2016;6:13-9.
- Rahimi J, Gholami J, Amin-Esmaeili M, Fotouhi A, Rafiemanesh H, Shadloo B, et al. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis. Addiction. 2020;115:605-22. doi: 10.1111/add.14853. PubMed PMID: 31631425.
- Napierala Mavedzenge S, Baggaley R, Corbett EL. A review of self-testing for HIV: research and policy priorities in a new era of HIV prevention. Clin Infect Dis. 2013;57:126-38. doi: 10.1093/cid/cit156. PubMed PMID: 23487385; PubMed Central PMCID: PMCPMC3669524.
- Kelley K, Clark B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. Int J Qual Health Care. 2003;15:261-6. doi: 10.1093/intqhc/mzg031. PubMed PMID: 12803354.
- Doosti-Irani A, Holakouie-Naieni K. Determination the Research Priorities in the Field of HIV/AIDS in Iran: A Systematic Review Article. Iran J Public Health. 2016;45:1149-58. PubMed PMID: 27957460; PubMed Central PMCID: PMCPMC5149469.
- McGregor S, Henderson KJ, Kaldor JM. How are health research priorities set in low and middle income countries? A systematic review of published reports. PLoS One. 2014;9:e108787. doi: 10.1371/journal.pone.0108787. PubMed PMID: 25275315; PubMed Central PMCID: PMCPMC4183511.
- Simbar M, Rahmanian F, Nazarpour S, Ramezankhani A, Zayeri F. Priorities for a gender-sensitive sexually transmitted infections and human immunodeficiency virus (STIs/HIV) services: An exploratory mixed methods study. Health Sci Rep. 2022;5:e553. doi: 10.1002/hsr2.553. PubMed PMID: 35308420; PubMed Central PMCID: PMCPMC8908080.
- Uneke CJ, Ezeoha AE, Ndukwe CD, Oyibo PG, Onwe F, Aulakh BK. Research priority setting for health policy and health systems strengthening in Nigeria: the policymakers and stakeholders perspective and involvement. Pan Afr Med J. 2013;16:10. doi: 10.11604/pamj.2013.16.10.2318. PubMed PMID: 24570781; PubMed Central PMCID: PMCPMC3926765.
- Owlia P, Eftekhari MB, Forouzan AS, Bahreini F, Farahani M, Ghanei M. Health research priority setting in Iran: Introduction to a bottom up approach. J Res Med Sci. 2011;16:691-8. PubMed PMID: 22091294; PubMed Central PMCID: PMCPMC3214383.
- Haghdoost A, Sadeghi M, Nasirian M, Mirzazadeh A, Navadeh S. Research priorities in the field of HIV and AIDS in Iran. J Res Med Sci. 2012;17:481-6. PubMed PMID: 23626616; PubMed Central PMCID: PMCPMC3634277.
- Feizzadeh A, Nedjat S, Asghari S, Keshtkar A, Heshmat R, Setayesh H, et al. Evidence-based approach to HIV/AIDS policy and research prioritization in the Islamic Republic of Iran. East Mediterr Health J. 2010;16:259-65. PubMed PMID: 20795438.
- Demetriou P, Abu-Shah E, Valvo S, McCuaig S, Mayya V, Kvalvaag A, et al. A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals. Nat Immunol. 2020;21:1232-43. doi: 10.1038/s41590-020-0770-x. PubMed PMID: 32929275; PubMed Central PMCID: PMCPMC7611174.
- Kapiriri L, Martin DK. Successful priority setting in low and middle income countries: a framework for evaluation. Health Care Anal. 2010;18:129-47. doi: 10.1007/s10728-009-0115-2. PubMed PMID: 19288200.
- Sahu D, Kumar P, Chandra N, Rajan S, Shukla DK, Venkatesh S, et al. Findings from the 2017 HIV estimation round & trend analysis of key indicators 2010-2017: Evidence for prioritising HIV/AIDS programme in India. Indian J Med Res. 2020;151:562-70. doi: 10.4103/ijmr.IJMR_1619_19. PubMed PMID: 32719229; PubMed Central PMCID: PMCPMC7602920.
- Xu JJ, Han MJ, Jiang YJ, Ding HB, Li X, Han XX, et al. Prevention and control of HIV/AIDS in China: lessons from the past three decades. Chin Med J (Engl). 2021;134:2799-809. doi: 10.1097/CM9.0000000000001842. PubMed PMID: 34759226; PubMed Central PMCID: PMCPMC8667973.
- Threats M, Brawner BM, Montgomery TM, Abrams J, Jemmott LS, Crouch PC, et al. A Review of Recent HIV Prevention Interventions and Future Considerations for Nursing Science. J Assoc Nurses AIDS Care. 2021;32:373-91. doi: 10.1097/JNC.0000000000000246. PubMed PMID: 33929980; PubMed Central PMCID: PMCPMC8715511.
- Beer L, Tie Y, Crim SM, Weiser J, Taussig J, Craw JA, et al. Progress Toward Achieving National HIV/AIDS Strategy Goals for Quality of Life Among Persons Aged >/=50 Years with Diagnosed HIV - Medical Monitoring Project, United States, 2017-2023. MMWR Morb Mortal Wkly Rep. 2024;73:781-7. doi: 10.15585/mmwr.mm7336a1. PubMed PMID: 39264841; PubMed Central PMCID: PMCPMC11392224 Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
- Stangl AL, Singh D, Windle M, Sievwright K, Footer K, Iovita A, et al. A systematic review of selected human rights programs to improve HIV-related outcomes from 2003 to 2015: what do we know? BMC Infect Dis. 2019;19:209. doi: 10.1186/s12879-019-3692-1. PubMed PMID: 30832599; PubMed Central PMCID: PMCPMC6399958.
)